$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today

Regeneron Pharmaceuticals REGN has outperformed the market over the past 5 years by 11.14% on an annualized basis producing an average annual return of 20.69%. Currently, Regeneron Pharmaceuticals has a market capitalization of $89.47 billion.

Buying $100 In REGN: If an investor had bought $100 of REGN stock 5 years ago, it would be worth $249.06 today based on a price of $818.39 for REGN at the time of writing.

Regeneron Pharmaceuticals's Performance Over Last 5 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.